Dmitriy Kolodin

Dmitriy Kolodin is an accomplished professional with extensive experience in clinical development operations and innovation within the pharmaceutical industry. Currently serving as Vice President of Clinical Development Operations at AbbVie since September 2019, Dmitriy oversees key areas including Immunology and Neuroscience. Previously, Dmitriy held the position of Associate Partner at McKinsey & Company from January 2015 to September 2019 and completed doctoral and postdoctoral research at Harvard Medical School from 2008 to 2014. Dmitriy earned a Ph.D. in Immunology from Harvard University and a Bachelor of Science in Microbiology and Immunology from UC Santa Barbara.